QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAPharmaceutical-GradeChina Warehouse
What is RIPEX Blend (Trenbolone Acetate 75mg + Drostanolone Propionate 75mg + Testosterone Propionate 75mg)?
RIPEX 225 is a balanced short-ester triple-compound research preparation delivering Trenbolone Acetate 75mg/mL, Drostanolone Propionate 75mg/mL, and Testosterone Propionate 75mg/mL in equal proportions. Equal-ratio design simplifies serum concentration attribution per compound in multi-analyte research. All three esters provide rapid onset kinetics. Research use only.
Research Applications
Equal-Ratio Multi-Compound PK
Equimolar serum profiling of TrenAce/MastoP/TestP — simplified attribution per compound
Short-Ester Androgen Synergy
Combined AR occupancy, SHBG displacement, and androgenic pathway activation
Trenbolone + Testosterone Interaction
Estradiol suppression, DHT competition, NET androgen effect modelling
Drostanolone Anti-Estrogen Research
SHBG competition and direct estrogen receptor antagonism in multi-compound context
Rapid-Clearance Multi-Compound Design
Short-ester washout kinetics for sequential or crossover research protocols
Quick Specs
| Form | Injectable solution |
| Concentration | 225mg/mL |
| CAS | 10161-34-9 / 521-12-0 / 57-85-2 |
| Molecular Formula | TrenAce C₂₀H₂₄O₃ + MastoP C₂₃H₃₆O₃ + TestP C₂₂H₃₂O₃ |
| MW | 372.5 / 360.5 / 344.5 |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Vehicle | Pharmaceutical-grade oil (USP/BP) |
| Storage | Room temperature 15–25°C | Protect from light | Do not freeze |
| Shelf Life | 24 months (unopened) |

